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AMONG the properties of human breast
carcinomata which have been correlated
with the likelihood of response to endo-
crine therapy are elastosis and high-
affinity oestrogen binding activity. Tu-
mours showing elastosis have been re-
ported to have a better prognosis and
to be more likely to respond to adrenal-
ectomy than those without this feature
(Shivas and Douglas, 1972). Similarly,
tumours which have detectable oestrogen
receptor activity are reported to respond
more frequently to a variety of endocrine
manipulations than those without this
activity (Desombre et al., 1974; McGuire
et al., 1 975). The assessment of elastosis
is rapid and simple, whereas that for
high-affinity oestrogen receptor activity
is time-consuming anll requires greater
expertise. The present study was under-
taken to determine whether an association
exists betweein these two features.
120 human primary breast tumour
biopsies were collected from the operating
theatre. One sample of at least 160 mg
was used for the detection of oestrogen
receptors, and a contiguous sample was
fixed in formal salinie for the assessment
of elastosis.
High-affinity oestrogen receptors were
measured using the method described
by Hawkins, Hill and Freedman (1975).
In order to simplify the data the oestrogen
receptors were categorized as plus (present
in quantities greater than 01 fmol/mg
wet weight of tissue) or minus (less than
041 fmol/mg wet weight of tissue).
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Elastosis was demonstrated in paraffin
sections using a modified Gomori aldehyde
fuchsin stain, as described by Shivas and
Douglas (1972). The tumours were grad-
ed according to the amount of elastosis
into categories 0, 1 and 2, where 0 indicates
that elastosis was not demonstrable, 1
indicates that elastosis was present in
small or moderate amounts, and 2 indi-
cates the presence of a gross amount of
elastosis.
The results are summarized in Table I,
and show that there is a definite associa-
tion between elastosis and presence or
absence of oestrogen receptors in hutman
breast carciniomata. The degree of asso-
ciation between the grades of elastosis
and the presence or absence of oestrogen
receptors was assessed using a x2 test
(for the 3 x 2 contingency Table 1),
and it was shown to be significaint
(P < 0.005). Oestrogen receptors were
detected in 450 of those tumours con-
taining grade 0 elastosis, 75%o of those
TABLE I. The Frequency of Occurrence
of Elastosis and High Affinity Oestroyen




category Nutmber 0 1 2
i87 10 ( 16) .59 (57) IS8 ( 141
:33 12 (6) 20 (22) 1 (5)
Total 120 22 79 19
The figurl'es in parenithesis iindlicate the e)xpecte(I
nutimbers in each cell ifelastosis grading an(I presence
or absence of oestrogen receptors are indepenldent.ELASTOSIS AND OESTROGEN RECEPTORS 343
with grade 1 elastosis and 95% of those
with grade 2 elastosis.
DISCUSSION
A definite association has been demon-
strated between elastosis and high-affinity
oestrogen receptors in human primary
breast carcinomata. This was particu-
larly striking in the 19 tumours containing
a gross amount of elastosis (grade 2),
18 of which were receptor positive.
However, the correlation is not sufficiently
strong to allow the substitution of the
elastica index for the measurement of
oestrogen receptor activity. Further
studies are in progress to determine the
relative merits of the assessment of
elastosis and oestrogen receptor activity
as predictive indices for response to a
variety of endocrine manipulations. Pre-
liminary studies indicate that little or
no elastosis is present in metastatic
deposits.
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